Answers are grounded in this paper and cite their sources.
GOAL: To present data from published clinical trials of treatment of patients with prostate cancer with enzalutamide described in plain language and in a dashboard format available at: https://clinical-trials.dimensions.ai/enzalutamide-clinical-review/. RATIONALE: Treatments that are clinically active in advanced prostate cancer may benefit patients as they are treated earlier in the disease. OBJECTIVE: To show how overall survival improves as patients are treated with enzalutamide earlier in the disease.
No takes yet. Share an insight, caveat, or question.
Dato et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: